Latest Glycated hemoglobin Stories

Years later participants see benefits of good blood sugar control in reducing slow-progressing complications Maintaining good glucose control early in the course of type 1 diabetes could lessen the long-term risk of kidney disease, as measured by a common test of kidney function. This finding comes from more than two decades of research on preventing life-shortening complications of type 1 diabetes. The National Institutes of Health (NIH) funded the longitudinal study. Results will be...

Diabetics with kidney failure shouldn't lower their blood glucose as much as diabetics without kidney failure Highlights:     Diabetic patients with kidney failure benefit the most when their hemoglobin A1C levels, which reflect blood glucose levels, are between 7% and 8%.     For diabetics who need dialysis, hemoglobin A1C levels of 8% or greater or less than 7% put them at increased risk of dying prematurely compared to patients with levels between 7.0% and 7.9%. Two...

Experts From Montefiore Medical Center Available for Interviews November 2011 is Diabetes Awareness Month BRONX, N.Y., Nov. 4, 2011 /PRNewswire-USNewswire/ -- The following is being released today by Montefiore Medical Center: More than Half of All Americans Will Have Diabetes by 2020 - Ranks Could Swell to 135 million Half of all American adults are destined to develop diabetes or pre-diabetes by 2020 if they don't make dramatic lifestyle changes, according to a dire new prediction from...

According to the regulators at the U.S. Food and Drug Administration, they will need three more months of research to determine the approval status of a new type of diabetes medication developed by Bristol-Myers Squibb and AstraZeneca as reported by DiabeticLive.com. Orlando, FL (PRWEB) October 28, 2011 According to the regulators at the U.S. Food and Drug Administration, they will need three more months of research to determine the approval status of a new type of diabetes medication...

BRIDGEWATER, N.J., Oct. 26, 2011 /PRNewswire/ -- The global and diversified healthcare leader Sanofi is currently conducting a research study to determine if lowering blood sugar levels can prevent future cardiovascular events. Currently being conducted at more than 150 sites across North America, this study may change the future treatment landscape for type 2 diabetics who suffer multiple cardiac events throughout their lifetimes. The Sanofi study, known as ELIXA, is researching whether...

SAN DIEGO, Oct. 21, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced positive results from two Phase 2 clinical trials of its ultrafast PH20 insulin analog formulations in patients with Type 1 and Type 2 diabetes. Both trials met the primary endpoint of non-inferiority of HbA1C compared to the...

Patients with diabetes face daily challenges in managing their blood glucose levels, and it has been postulated that patients could benefit from a system providing continuous real-time glucose readings. Today, The Endocrine Society released a clinical practice guideline (CPG) providing recommendations on settings where patients are most likely to benefit from continuous glucose monitoring (CGM). The most common way to self-check blood glucose levels is to prick the skin to get a drop of...

(Ivanhoe Newswire) -- People with type 2 diabetes who intensively lower their blood sugar are not preventing cognitive decline, according to new research. Individuals with type 2 diabetes who are older than age 70 are twice as likely to develop cognitive impairment that is linked to their disease than those without diabetes. A team of researchers studied nearly 3,000 patients aged 55 years who had type 2 diabetes and were at risk for cardiovascular disease. These individuals also had...

Intensive treatment provides no benefit over standard when it comes to memory Intensive control of blood sugar levels beyond standard targets provides no additional protection against cognitive decline in older people with diabetes than standard treatment, according to a national study coordinated by researchers at Wake Forest Baptist Medical Center. The first results of the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) study appear online today in...

Doctor-patient encounters associated with lower blood glucose, cholesterol and blood pressure levels in patients with diabetes The risk for diabetes complications, such as heart attack and stroke, increases with high blood glucose, blood pressure and cholesterol levels. Reducing risk means reducing these values to ideal levels. According to researchers at Brigham and Women's Hospital (BWH), achieving ideal levels may be as simple as seeing your doctor. They found that frequent...